NCT05456191
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT05456191
Title A Study to Investigate Tolerability and Efficacy of Asciminib (Oral) Versus Nilotinib (Oral) in Adult Participants (>=18 Years of Age) With Newly Diagnosed Philadelphia Chromosome Positive Chronic Myelogenous Leukemia in Chronic Phase (Ph+ CML-CP) (ASC4START)
Acronym ASC4START
Recruitment Active, not recruiting
Gender both
Phase Phase III
Variant Requirements No
Sponsors Novartis Pharmaceuticals
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA | TUR | SVK | ROU | NLD | ITA | HUN | GRC | GBR | FRA | DEU | CZE | CHE | CAN | BGR | ARG

Facility Status City State Zip Country Details
Rocky Mountain Cancer Centers Boulder Colorado 80304 United States Details
Illinois Cancer Care Peoria Illinois 61615 United States Details
Regions Hospital Saint Paul Minnesota 55101 United States Details
Messino Cancer Centers Asheville North Carolina 28806 United States Details
Oncology Hematology Care Inc Cincinnati Ohio 45242 United States Details
Williamette Cancer Center Eugene Oregon 97401 United States Details
Texas Oncology P A Bedford Texas 76022 United States Details
Texas Oncology PA Bedford Bedford Texas 76022 United States Details
Virginia Oncology Associates Norfolk Virginia 23502 United States Details
Novartis Investigative Site CABA Buenos Aires C1181ACH Argentina Details
Novartis Investigative Site CABA Buenos Aires C1221ADH Argentina Details
Novartis Investigative Site Buenos Aires C1039AAC Argentina Details
Novartis Investigative Site Buenos Aires C1114AAN Argentina Details
Novartis Investigative Site Buenos Aires C1425AUM Argentina Details
Novartis Investigative Site Pleven 5800 Bulgaria Details
Novartis Investigative Site Plovdiv 4002 Bulgaria Details
Novartis Investigative Site Sofia 1431 Bulgaria Details
Novartis Investigative Site Sofia 1797 Bulgaria Details
Novartis Investigative Site Varna 9010 Bulgaria Details
Novartis Investigative Site London Ontario N6A 5W9 Canada Details
Novartis Investigative Site Toronto Ontario M5G 2M9 Canada Details
Novartis Investigative Site Brno 625 00 Czechia Details
Novartis Investigative Site Plzen Bory 301 00 Czechia Details
Novartis Investigative Site Prague 100 34 Czechia Details
Novartis Investigative Site Prague 128 00 Czechia Details
Novartis Investigative Site Bordeaux 33076 France Details
Novartis Investigative Site Caen 14033 France Details
Novartis Investigative Site Clermont-Ferrand 63003 France Details
Novartis Investigative Site Lille 59037 France Details
Novartis Investigative Site Lyon 69373 France Details
Novartis Investigative Site Marseille 13273 France Details
Novartis Investigative Site Nantes 44093 France Details
Novartis Investigative Site Nice 06202 France Details
Novartis Investigative Site Paris 75475 France Details
Novartis Investigative Site Poitiers 86021 France Details
Novartis Investigative Site Strasbourg 67200 France Details
Novartis Investigative Site Toulouse 31059 France Details
Novartis Investigative Site Vandœuvre-lès-Nancy 54511 France Details
Novartis Investigative Site Freiburg im Breisgau Baden-Wurttemberg 79106 Germany Details
Novartis Investigative Site Mannheim Baden-Wurttemberg 68305 Germany Details
Novartis Investigative Site Munich Bavaria 81241 Germany Details
Novartis Investigative Site Würzburg Bavaria 97080 Germany Details
Novartis Investigative Site Frankfurt am Main Hesse 60590 Germany Details
Novartis Investigative Site Marburg Hesse 35043 Germany Details
Novartis Investigative Site Velbert North Rhine-Westphalia 42551 Germany Details
Novartis Investigative Site Dresden Saxony 01307 Germany Details
Novartis Investigative Site Leipzig Saxony 04103 Germany Details
Novartis Investigative Site Halle Saxony-Anhalt 06120 Germany Details
Novartis Investigative Site Jena Thuringia 07740 Germany Details
Novartis Investigative Site Aachen 52074 Germany Details
Novartis Investigative Site Augsburg 86179 Germany Details
Novartis Investigative Site Bad Saarow 15526 Germany Details
Novartis Investigative Site Bayreuth 95445 Germany Details
Novartis Investigative Site Berlin 13353 Germany Details
Novartis Investigative Site Bonn 53105 Germany Details
Novartis Investigative Site Bremen 28205 Germany Details
Novartis Investigative Site Chemnitz 09113 Germany Details
Novartis Investigative Site Erlangen 91054 Germany Details
Novartis Investigative Site Essen 45147 Germany Details
Novartis Investigative Site Hamburg 20246 Germany Details
Novartis Investigative Site Hanover 30161 Germany Details
Novartis Investigative Site Heidelberg 69120 Germany Details
Novartis Investigative Site Lübeck 23538 Germany Details
Novartis Investigative Site Magdeburg 39104 Germany Details
Novartis Investigative Site München 80377 Germany Details
Novartis Investigative Site Paderborn 33098 Germany Details
Novartis Investigative Site Regensburg 93049 Germany Details
Novartis Investigative Site Tübingen 72076 Germany Details
Novartis Investigative Site Ulm 89081 Germany Details
Novartis Investigative Site Athens 106 76 Greece Details
Novartis Investigative Site Athens 115 27 Greece Details
Novartis Investigative Site Ioannina 455 00 Greece Details
Novartis Investigative Site Pátrai 265 04 Greece Details
Novartis Investigative Site Thessaloniki 570 10 Greece Details
Novartis Investigative Site Budapest H-1083 Hungary Details
Novartis Investigative Site Budapest H-1097 Hungary Details
Novartis Investigative Site Eger 3300 Hungary Details
Novartis Investigative Site Ahmedabad Gujarat 380009 India Details
Novartis Investigative Site Chennai Tamil Nadu 600036 India Details
Novartis Investigative Site Varanasi Uttar Pradesh 221010 India Details
Novartis Investigative Site Rishikesh Uttarakhand 249203 India Details
Novartis Investigative Site New Delhi 110029 India Details
Novartis Investigative Site Meldola FC 47014 Italy Details
Novartis Investigative Site Milan MI 20162 Italy Details
Novartis Investigative Site Pisa PI 56126 Italy Details
Novartis Investigative Site Roma RM 00144 Italy Details
Novartis Investigative Site Torino TO 10126 Italy Details
Novartis Investigative Site Amman 11941 Jordan Details
Novartis Investigative Site Alor Star Kedah 05460 Malaysia Details
Novartis Investigative Site Kuching Sarawak 93586 Malaysia Details
Novartis Investigative Site Petaling Jaya Selangor 46150 Malaysia Details
Novartis Investigative Site Kuala Lumpur 59100 Malaysia Details
Novartis Investigative Site Dordrecht South Holland 3318 AT Netherlands Details
Novartis Investigative Site Khoudh 123 Oman Details
Novartis Investigative Site Târgu Mureş Mureș County 540136 Romania Details
Novartis Investigative Site Bucharest 021494 Romania Details
Novartis Investigative Site Bucharest 022328 Romania Details
Novartis Investigative Site Bucharest 030 171 Romania Details
Novartis Investigative Site Cluj-Napoca 400124 Romania Details
Novartis Investigative Site Craiova 200136 Romania Details
Novartis Investigative Site Sibiu 550245 Romania Details
Novartis Investigative Site Timișoara 300079 Romania Details
Novartis Investigative Site Singapore 119074 Singapore Details
Novartis Investigative Site Singapore 169608 Singapore Details
Novartis Investigative Site Singapore S308433 Singapore Details
Novartis Investigative Site Bratislava 851 07 Slovakia Details
Novartis Investigative Site Soweto Gauteng 2013 South Africa Details
Novartis Investigative Site Pretoria 0044 South Africa Details
Novartis Investigative Site Bundang Gu Gyeonggi-do 13620 South Korea Details
Novartis Investigative Site Uijeongbu-si Gyeonggi-do 11759 South Korea Details
Novartis Investigative Site Geneva 1211 Switzerland Details
Novartis Investigative Site Istanbul Fatih 34098 Turkey (Türkiye) Details
Novartis Investigative Site Ankara Sihhiye-Altindag 06230 Turkey (Türkiye) Details
Novartis Investigative Site Izmir 35100 Turkey (Türkiye) Details
Novartis Investigative Site Abu Dhabi 00000 United Arab Emirates Details
Novartis Investigative Site Glasgow G12 0YN United Kingdom Details
Novartis Investigative Site Gloucester GL1 3NN United Kingdom Details
Novartis Investigative Site London SE5 9RS United Kingdom Details
Novartis Investigative Site London W12 0HS United Kingdom Details
Novartis Investigative Site Newport NP20 2UB United Kingdom Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field